Argenx
Argenx SE, a leading biotechnology company, is headquartered in Breda, Netherlands, with significant operations in the United States and Europe. Founded in 2008, Argenx focuses on developing innovative therapies for severe autoimmune diseases and cancer, leveraging its proprietary antibody engineering platform. The company’s flagship product, efgartigimod, has garnered attention for its unique mechanism of action, targeting the neonatal Fc receptor to reduce pathogenic IgG antibodies. Argenx has achieved notable milestones, including successful clinical trials and strategic partnerships, positioning itself as a key player in the biopharmaceutical industry. With a commitment to advancing patient care, Argenx continues to push the boundaries of treatment options in its specialised fields.
DitchCarbon Score
How does Argenx's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Development industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Argenx's score of 26 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Argenx's reported carbon emissions
In 2023, Argenx reported total carbon emissions of approximately 433,353 tonnes CO2e. This figure includes 378 tonnes CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources. Scope 2 emissions, related to the generation of purchased electricity, steam, heating, and cooling, accounted for about 189 tonnes CO2e (market-based). The majority of Argenx's emissions stem from Scope 3, totalling approximately 432,786 tonnes CO2e, which includes significant contributions from purchased goods and services (about 378,956 tonnes CO2e) and business travel (approximately 5,328 tonnes CO2e). Currently, Argenx has not established specific reduction targets or initiatives as part of their climate commitments. However, the company is aware of the importance of addressing carbon emissions and is likely to consider future strategies to enhance sustainability and reduce their environmental impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2023 | |
|---|---|
| Scope 1 | 378,000 |
| Scope 2 | 189,000 |
| Scope 3 | 432,786,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Argenx is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
